However, when combined with radiation, anti-CCR2 significantly enhanced the efficacy of tumor regression compared to IR alone (144 ± 71 vs. 540 ± 151 on day 43, P < 0.01: Student’s t-test). The gene discussed is CCR2; the disease is neoplasm.